These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 30541416)
1. Anti-PD1 'SHR-1210' aberrantly targets pro-angiogenic receptors and this polyspecificity can be ablated by paratope refinement. Finlay WJJ; Coleman JE; Edwards JS; Johnson KS MAbs; 2019 Jan; 11(1):26-44. PubMed ID: 30541416 [TBL] [Abstract][Full Text] [Related]
2. Sym021, a promising anti-PD1 clinical candidate antibody derived from a new chicken antibody discovery platform. Gjetting T; Gad M; Fröhlich C; Lindsted T; Melander MC; Bhatia VK; Grandal MM; Dietrich N; Uhlenbrock F; Galler GR; Strandh M; Lantto J; Bouquin T; Horak ID; Kragh M; Pedersen MW; Koefoed K MAbs; 2019; 11(4):666-680. PubMed ID: 31046547 [TBL] [Abstract][Full Text] [Related]
3. Comparison of "framework Shuffling" and "CDR Grafting" in humanization of a PD-1 murine antibody. Wang Y; Chen YL; Xu H; Rana GE; Tan X; He M; Jing Q; Wang Q; Wang G; Xie Z; Wang C Front Immunol; 2024; 15():1395854. PubMed ID: 39076979 [TBL] [Abstract][Full Text] [Related]
4. SDR grafting of a murine antibody using multiple human germline templates to minimize its immunogenicity. Gonzales NR; Padlan EA; De Pascalis R; Schuck P; Schlom J; Kashmiri SV Mol Immunol; 2004 Jul; 41(9):863-72. PubMed ID: 15261458 [TBL] [Abstract][Full Text] [Related]
5. Deep Sequencing-guided Design of a High Affinity Dual Specificity Antibody to Target Two Angiogenic Factors in Neovascular Age-related Macular Degeneration. Koenig P; Lee CV; Sanowar S; Wu P; Stinson J; Harris SF; Fuh G J Biol Chem; 2015 Sep; 290(36):21773-86. PubMed ID: 26088137 [TBL] [Abstract][Full Text] [Related]
6. Balancing charge in the complementarity-determining regions of humanized mAbs without affecting pI reduces non-specific binding and improves the pharmacokinetics. Datta-Mannan A; Thangaraju A; Leung D; Tang Y; Witcher DR; Lu J; Wroblewski VJ MAbs; 2015; 7(3):483-93. PubMed ID: 25695748 [TBL] [Abstract][Full Text] [Related]
7. The interplay of non-specific binding, target-mediated clearance and FcRn interactions on the pharmacokinetics of humanized antibodies. Datta-Mannan A; Lu J; Witcher DR; Leung D; Tang Y; Wroblewski VJ MAbs; 2015; 7(6):1084-93. PubMed ID: 26337808 [TBL] [Abstract][Full Text] [Related]
8. Grafting of "abbreviated" complementarity-determining regions containing specificity-determining residues essential for ligand contact to engineer a less immunogenic humanized monoclonal antibody. De Pascalis R; Iwahashi M; Tamura M; Padlan EA; Gonzales NR; Santos AD; Giuliano M; Schuck P; Schlom J; Kashmiri SV J Immunol; 2002 Sep; 169(6):3076-84. PubMed ID: 12218124 [TBL] [Abstract][Full Text] [Related]
9. Humanization by CDR grafting and specificity-determining residue grafting. Kim JH; Hong HJ Methods Mol Biol; 2012; 907():237-45. PubMed ID: 22907355 [TBL] [Abstract][Full Text] [Related]
10. Antibody humanization by structure-based computational protein design. Choi Y; Hua C; Sentman CL; Ackerman ME; Bailey-Kellogg C MAbs; 2015; 7(6):1045-57. PubMed ID: 26252731 [TBL] [Abstract][Full Text] [Related]
11. Antibody humanization by redesign of complementarity-determining region residues proximate to the acceptor framework. Hanf KJ; Arndt JW; Chen LL; Jarpe M; Boriack-Sjodin PA; Li Y; van Vlijmen HW; Pepinsky RB; Simon KJ; Lugovskoy A Methods; 2014 Jan; 65(1):68-76. PubMed ID: 23816785 [TBL] [Abstract][Full Text] [Related]
12. SDR grafting--a new approach to antibody humanization. Kashmiri SV; De Pascalis R; Gonzales NR; Schlom J Methods; 2005 May; 36(1):25-34. PubMed ID: 15848072 [TBL] [Abstract][Full Text] [Related]
13. Humanization of rabbit monoclonal antibodies via grafting combined Kabat/IMGT/Paratome complementarity-determining regions: Rationale and examples. Zhang YF; Ho M MAbs; 2017 Apr; 9(3):419-429. PubMed ID: 28165915 [TBL] [Abstract][Full Text] [Related]
14. Grabbing the Bull by Both Horns: Bovine Ultralong CDR-H3 Paratopes Enable Engineering of 'Almost Natural' Common Light Chain Bispecific Antibodies Suitable For Effector Cell Redirection. Klewinghaus D; Pekar L; Arras P; Krah S; Valldorf B; Kolmar H; Zielonka S Front Immunol; 2021; 12():801368. PubMed ID: 35087526 [TBL] [Abstract][Full Text] [Related]
15. Antibody humanization methods - a review and update. Safdari Y; Farajnia S; Asgharzadeh M; Khalili M Biotechnol Genet Eng Rev; 2013; 29():175-86. PubMed ID: 24568279 [TBL] [Abstract][Full Text] [Related]
16. Antibody Fragments Humanization: Beginning with the End in Mind. Aubrey N; Billiald P Methods Mol Biol; 2019; 1904():231-252. PubMed ID: 30539473 [TBL] [Abstract][Full Text] [Related]
17. Off-target binding of an anti-amyloid beta monoclonal antibody to platelet factor 4 causes acute and chronic toxicity in cynomolgus monkeys. Loberg LI; Chhaya M; Ibraghimov A; Tarcsa E; Striebinger A; Popp A; Huang L; Oellien F; Barghorn S MAbs; 2021; 13(1):1887628. PubMed ID: 33596779 [TBL] [Abstract][Full Text] [Related]
18. A two-in-one antibody engineered from a humanized interleukin 4 antibody through mutation in heavy chain complementarity-determining regions. Lee CV; Koenig P; Fuh G MAbs; 2014; 6(3):622-7. PubMed ID: 24618680 [TBL] [Abstract][Full Text] [Related]
19. Affinity maturation of a humanized rat antibody for anti-RAGE therapy: comprehensive mutagenesis reveals a high level of mutational plasticity both inside and outside the complementarity-determining regions. Finlay WJ; Cunningham O; Lambert MA; Darmanin-Sheehan A; Liu X; Fennell BJ; Mahon CM; Cummins E; Wade JM; O'Sullivan CM; Tan XY; Piche N; Pittman DD; Paulsen J; Tchistiakova L; Kodangattil S; Gill D; Hufton SE J Mol Biol; 2009 May; 388(3):541-58. PubMed ID: 19285987 [TBL] [Abstract][Full Text] [Related]
20. A comprehensive search of functional sequence space using large mammalian display libraries created by gene editing. Parthiban K; Perera RL; Sattar M; Huang Y; Mayle S; Masters E; Griffiths D; Surade S; Leah R; Dyson MR; McCafferty J MAbs; 2019 Jul; 11(5):884-898. PubMed ID: 31107136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]